期刊文献+

人重组IL-17/His蛋白的原核表达、纯化及其生物学活性 被引量:8

Prokaryotic expression,purification and biological activity of recombinant human IL-17/His protein
下载PDF
导出
摘要 目的:研究人IL-17的体外生物学活性。方法:采用RT-PCR的方法克隆得到了hIL-17基因序列。将测序正确的人IL-17基因装入PQE3.0原核表达载体构建重组载体hIL-17/PQE3.0。该重组载体导入宿主菌M15,经异丙基β-D硫代半乳糖苷(IPTG)诱导产生IL-17/His融合蛋白,并经West-ernblot实验确认。结果:原核表达的hIL-17/His重组蛋白经变性、复性后,利用HiTrapTM亲和层析得到纯品蛋白。体外活性实验表明,该融合蛋白具有刺激人宫颈癌细胞株HeLa分泌IL-6和GM-CSF的作用。结论:制备了具有生物学活性的IL-17/His重组蛋白,为进一步研究该分子在自身免疫疾病等方面的作用奠定了基础。 AIM: To investigate the biological activity of recombinant human IL-17 protein in vitro. METHODS: The gene region of human IL-17 was cloned by RT-PCR. After identification by sequencing, the hlL-17 gene encoding function domain was cloned into expression plasmid PQE3.0 and transfect into E. coli M15. By the induction of Isopropyl- 13-D-Thiogalacto-Pyranoside ( IPTG), recombinant IL-17/His protein was effectively expressed in E. coil M15. The recombinant protein was identified by Western blot. RESULTS: After denaturation, renaturation and purification by HiTrapTM affinity column, the recombinant protein stimulated HeLa, a human uterine cervix cancer cell line, to excrete IL-6 and GM-CSF in vitro. CONCLUSION: IL-17/His reconbinant protein is of high biological activity, which can be used to make further study of auto-immune diseases.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第8期715-718,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金重点资助项目(30330540)
关键词 IL-17 原核表达 复性 纯化 IL-17 prokaryotic expression renaturation purification
  • 相关文献

参考文献10

  • 1Rouvier E,Luciani MF,Mttei MG,et al.CTLA-8,cloned from an activated T cell,bearing AU-Rich messenger RNA instability sequence,and homlogous to a Herpesvirus Saimiri gene[J].J Immunol,1993,150(12):5445-5456.
  • 2Yao Z,Fanslow WC,Seldin MF,et al.Herpesvirus Saimiri encodes a new cytokine,IL-17,which binds to a novel cytokine receptor[J].Immunity,1995,3(6):811-821.
  • 3Laan M,Cui ZH,Hoeshino H,et al.Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the air ways[J].J Immunol,1999,162(4):2347-2352.
  • 4Miossec P.Interleukin-17 in rheumatoid arthritis:if T cells were to contribute to inflammation and destruction through synergy[J].Arthritis Rheum,2003,48(3):594-601.
  • 5Moseley TA,Haudenschild DR,Rose L,et al.Interleukin-17 family and IL-17 receptors[J].Cytokine Growth Factor Rev,2003,14(2):155-174.
  • 6Park H,Li Z,Yang XO,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J].Nat Immunol,2005,6(11):1133-1141.
  • 7Bettelli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
  • 8Weaver CT,Harrington LE,Mangan PR,et al.Th17:an effector CD4 T cell lineage with regulatory T cell ties[J].Immunity,2006,24(6):677-688.
  • 9Gunimaladevi I,Savan R,Sakai M.Identification,cloning and characterization of interleukin-17 and its family from zebrafish[J].Fish Shellfish Immunol,2006,21(4):393-403.
  • 10李青,吴雄文,熊敏,翁秀芳,卢小玲,梁智辉,龚非力.BirA酶基因表达载体的构建、原核表达及表达产物的活性鉴定[J].细胞与分子免疫学杂志,2005,21(5):557-560. 被引量:9

二级参考文献8

  • 1Barker DF, Campbell AM. The birA gene of Escherichia coli encodes abiotin holoenzyme synthetase[J]. J Mol Biol, 1981, 146(4): 451-467.
  • 2Barker DF, Campbell AM. Genetic and biochemical characterization ofthe birA gene and its product: evidence for a direct role of biotinholoenzyme synthetase in repression of the biotin operon in Escherichiacoli[J]. J Mol Biol, 1981, 146(4): 469-492.
  • 3Gillespie G, Mutis T, Schrama E, et al. HLA class I-minorhistocompatibility antigen tetramers select cytotoxic T cells with highavidity to the natural ligand[J]. Hematol J, 2000, 1(6): 403-410.
  • 4Schatz PJ. Use of peptide libraries to map the substrate specificityof a peptide-modifying enzyme: a 13 residue consensus peptide specifiesbiotinylation in Escherichia coli[J]. Biotechnology (NY), 1993, 11(10):1138-1143.
  • 5Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis ofantigen-specific T lymphocytes[J]. Science, 1996, 274(5284): 94-96.
  • 6Ladasky JJ, Shum BP, Canavez F, et al. Residue 3 ofbeta2-microglobulin affects binding of class I MHC molecules by the W6/32antibody[J]. Immunogenetics, 1999, 49(4): 312-320.
  • 7O'callaghan CA, Byford MF, Wyer JR, et al. BirA enzyme: production andapplication in the study of membrane receptor-ligand interactions bysite-specific biotinylation[J]. Anal Biochem, 1999, 266(1): 9-15.
  • 8翁秀芳,陈浩,吴雄文,梁智辉,韩军艳,黄亚非,龚非力.可溶性HLA-A2-肽复合物的体外折叠与生物素化[J].细胞与分子免疫学杂志,2004,20(3):265-268. 被引量:10

共引文献8

同被引文献76

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部